Brian Booth

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• The University of Texas MD Anderson Cancer Center15.5%
• United States Food and Drug Administration11.7%
• Bristol-Myers Squibb (United States)7.3%
• Pfizer (United States)7.2%
• Inserm6.7%
• University of California, San Francisco6.3%
• Other45.1%

Fields

• Medicine56.3%
• Biochemistry, Genetics and Molecular Biology22.3%
• Immunology and Microbiology8.3%
• Pharmacology, Toxicology and Pharmaceutics3.8%
• Chemistry2.5%
• Agricultural and Biological Sciences1.5%
• Other5.2%

Topics

• Biosimilars and Bioanalytical Methods11.5%
• HER2/EGFR in Cancer Research10.2%
• Lung Cancer Treatments and Mutations9.1%
• Chronic Myeloid Leukemia Treatments8.8%
• Cancer Immunotherapy and Biomarkers7.1%
• Monoclonal and Polyclonal Antibodies Research6.8%
• Other46.5%